Tirzepatide is a medication that activates both GIP and GLP-1 receptors to enhance insulin secretion, reduce appetite, and slow gastric emptying, leading to significant weight loss and improved blood sugar control
He provides in-person and virtual care for patients in Salt Lake City , St
Some people carry genetic variants that make them naturally better responders to GLP-1 therapy, while others may need dual-pathway activation to see significant results
Liver Health Management: There is significant potential for Orforglipron to reduce liver fat and inflammation in patients suffering from non-alcoholic steatohepatitis
What Else Can Help With Weight Control
The use of DPP-4is as a comparator provided a highly comparable control group, particularly as both drugs were used in the setting of sole add-on medication to metformin, and both drugs have similar priority in the management of T2D